Fresh off earning FDA approval for a prefilled syringe version of Vyvgart Hytrulo for at-home administration, argenx is building buzz with a new direct-to-consumer campaign. The “Treatment MY ...

Dual chamber prefilled syringes market is estimated to be valued at $ 184.7 Mn in 2025, and is expected to reach $ 306.6 Mn by 2032, exhibiting a CAGR of 7.5%. BURLINGAME, CA, UNI ...

The desire for patients to have a personalized approach to care is repeated throughout the ad, which was produced by Avalere ...

Selardsdi is indicated for the treatment of moderate to severe plaque psoriasis and active psoriatic arthritis in adults and ...

Strong financials, 7% sales growth, Vision 2030 focus, & patient-centric innovation with self-injection solutions ...

Copaxone and generic versions of glatiramer acetate are injected under the skin at 20 mg/mL daily or 40 mg/mL three times a ...

Amneal Pharmaceuticals inked a collaboration deal with syringe maker Apiject that will see the New Jersey-based biopharma ...

The company continues to build momentum with its innovative agenda and recently launched a pre-filled syringe for self-injection in the U.S. and Germany. CFO Karl Gubitz reported total operating ...

Zydus Lifesciences said that it has has received final approval from the United States Food and Drug Administration (USFDA) for Glatiramer Acetate Injection, 20 mg/mL and 40 mg/mL, single-dose ...

Quarter ResultsFormycon reports strong operational performance and financial results for first quarter of 2025 12.05.2025 / 06:30 CET/CESTThe issuer is solely responsible for the content of this ...

First patients treated with VYVGART Hytrulo pre-filled syringe for self-injection in US and Germany CIDP global expansion with positive CHMP opinion for VYVGART-SC (vial and pre-filled syringe) in EU ...

single-dose prefilled syringes. Zydus’ generic Glatiramer Acetate Injection is an FDA-approved, AP-rated substitutable generics of Copaxone ® 20 mg/ml, 40 mg/ml and indicated for the treatment ...